KRBA1 Activators
KRBA1 activators are a category of chemical compounds that engage a specific biological pathway by targeting and activating the KRBA1 protein. The KRBA1 protein, known in full as Keap1-Nrf2 Regulating Bromodomain-Associated 1, plays a crucial role within the cellular environment, primarily involved in the regulation of transcription factors, which are pivotal for controlling the expression of genes. By binding to this protein, KRBA1 activators influence the activity of pathways that are involved in the modulation of various cellular processes. These activators can be designed to exhibit high specificity, binding affinity, and potency towards the KRBA1 protein, affecting its interaction with other molecules within the cell.
The molecular structure of KRBA1 activators often includes a pharmacophore, the part of the molecule that is responsible for its biological activity, which enables it to bind precisely to the KRBA1 protein. The design of these activators might incorporate an array of functional groups that can form non-covalent interactions such as hydrogen bonds, van der Waals forces, and hydrophobic interactions with the target protein, thereby stabilizing the activator-KRBA1 complex. The specificity and selectivity of these compounds are of paramount importance, as they determine the exactitude with which these molecules activate the KRBA1 protein without off-target effects. Research and development in this chemical class focus on elucidating the precise mechanisms of action, the optimization of the molecular interactions, and understanding the structure-activity relationships (SAR) that govern the efficacy and specificity of the activators within biological systems.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate KRBA1, enhancing its functional activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, preventing cAMP breakdown, thus indirectly leading to PKA activation and subsequent phosphorylation of KRBA1. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can phosphorylate target proteins, potentially enhancing the activity of KRBA1 through downstream signaling effects. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule activates sphingosine-1-phosphate receptors, initiating signaling cascades that can modulate the activity of proteins like KRBA1 via protein-protein interactions. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration, which may activate calcium-dependent protein kinases, potentially leading to the activation of KRBA1. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromoadenosine 3',5'-cyclic monophosphate is a cAMP analog that activates PKA, and can thus enhance the phosphorylation and activation of KRBA1. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a potent antioxidant that can inhibit certain protein kinases, altering signaling pathways and potentially leading to an increase in KRBA1 activity through indirect effects on signaling balance. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that alters downstream AKT signaling, which may shift cellular signaling dynamics in a manner that indirectly enhances KRBA1 activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK, which may lead to the modulation of ERK signaling pathways, indirectly influencing KRBA1's activity through altered signal transduction. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium levels, which might activate calcium-dependent pathways, enhancing the activity of KRBA1. | ||||||